In this study, knockdown of CDK5 with siRNAs inhibits activation of AKT which significantly correlates with decreased cell growth and enhanced paclitaxel sensitivity in ovarian cancer cell lines. This evidence concerns the gene CDK5 and ovarian carcinoma.